How to deal with patients with atrial fibrillation during an epidemic?

Tomaszuk-Kazberuk, Anna

How to deal with patients with atrial fibrillation during an epidemic?

dc.contributor.author	Tomaszuk-Kazberuk, Anna
dc.contributor.organization	Medical University of Białystok	en
dc.date.accessioned	2021-06-09T13:18:56Z
dc.date.available	2021-06-09T13:18:56Z
dc.date.issued	2020-05-29
dc.description.abstract	Patients with atrial fibrillation (AF) due to old age and comorbidities are at a higher risk of SARS-CoV-2 infection. These patients should protect themselves by limiting contact with other people to an absolute minimum and they should be educated about hygiene, including careful hand washing. In general, the principles of antiarrhythmic drug treatment of quarantined, infected and asymptomatic individuals remain unchanged. In the hospital setting it is important to remember about possible interactions between anticoagulants, antibiotics, antiarrhythmic, antiviral and antimalarial drugs. The current pandemic also led to limitations regarding the implantation and control of implantable devices to an absolute minimum.	en
dc.identifier.citation	Tomaszuk-Kazberuk A. How to deal with patients with atrial fibrillation during an epidemic?. Eur J Transl Clin Med. 2020;3(1):53-59. DOI: 10.31373/ejtcm/120487	en
dc.identifier.issn	2657-3156
dc.identifier.uri	https://open.icm.edu.pl/handle/123456789/20176
dc.language.iso	en
dc.publisher	Medical University of Gdańsk	en
dc.rights	Uznanie autorstwa-Na tych samych warunkach 3.0 Polska	*
dc.rights.uri	http://creativecommons.org/licenses/by-sa/3.0/pl/	*
dc.subject	atrial fibrillation	en
dc.subject	coronavirus	en
dc.subject	infection	en
dc.subject	SARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus- 2	en
dc.subject	COVID-19	en
dc.subject	Coronavirus disease 2019	en
dc.subject	non-vitamin K oral anticoagulants (NOACs	en
dc.title	How to deal with patients with atrial fibrillation during an epidemic?	en
dc.type	article	en